# Altaris Capital Partners acquires 3M Drug Delivery Systems, launches Kindeva

Altaris Capital Partners has acquired 3M Drug Delivery Systems in a $650 million transaction, launching it as an independent company named Kindeva Drug Delivery, with 3M retaining a 17% minority interest.

- Type: Acquisition
- Announced: 2020-05-01
- Where: St. Paul, MN, Northridge, CA and UK, United States
- Value: $650.0M
- Status: completed
- Products: drug delivery systems
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [3M](https://endata.com/companies/3594.md) (target)
- [Altaris Capital Partners](https://endata.com/companies/31301.md) (acquirer)
- [Kindeva Drug Delivery](https://endata.com/companies/46943.md) (target)

## Sources

- [biospace.com](https://www.biospace.com/kindeva-drug-delivery-formerly-3m-drug-delivery-systems-launches-as-an-independent-company), 2020-05-01: "Kindeva Drug Delivery, formerly 3M Drug Delivery Systems, today announced its launch as an independent company following the acquisition by Altaris Capital Partners in a transaction valued at $650 million."
- [biopharminternational.com](https://www.biopharminternational.com/view/former-3m-drug-delivery-systems-launches-kindeva-drug-delivery-0), 2020-05-04: "We will be executing an ambitious growth plan that involves significant capital investment and the addition of new jobs across our operating regions."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.